General Results
Rheanna Grizzell

Rheanna Grizzell

Family and Community Medicine
Family and Community Medicine
General Results
Tori McNary

Tori McNary

Graduate student
General Results
Marah Elizabeth Willmore

Marah Elizabeth Willmore

Family and Community Medicine
Family and Community Medicine
General Results

MD admissions

Trial
Neurology

Caregiver Characteristics That May Predict When Patients With Alzheimer Disease Are Placed in Long Term Care Facilities

Active recruiting
This research will be conducted by the SIU Memory and Aging Network (MAN), which comprises 38 sites that evaluate and treat patients with dementia throughout non-metropolitan Illinois.  AD patients and their caregivers who are living in private homes will be recruited.  Primary outcome measures will be the ratings of the caregiver’s physical status (grip strength, walking speed, and score on the Timed Up-and-Go Test11 and the rating of the caregiver’s chronic medical illness burden using the Cumulative Illness Rating Scale (Geriatric).12,13  The patient and caregiver dyad is required.
Contact: Stephanie Kohlrus 217-545-3013
Trial
Neurology

Caregiver Characteristics That May Predict When Patients With Alzheimer Disease Are Placed in Long Term Care Facilities

Active recruiting
This research will be conducted by the SIU Memory and Aging Network (MAN), which comprises 38 sites that evaluate and treat patients with dementia throughout non-metropolitan Illinois.  AD patients and their caregivers who are living in private homes will be recruited.  Primary outcome measures will be the ratings of the caregiver’s physical status (grip strength, walking speed, and score on the Timed Up-and-Go Test11 and the rating of the caregiver’s chronic medical illness burden using the Cumulative Illness Rating Scale (Geriatric).12,13  The patient and caregiver dyad is required.
Contact: Stephanie Kohlrus 217-545-3013
Trial
Neurology

Roche: A Phase IIB, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of intravenous prasinezumab in participants with early Parkinson's disease

Active not recruiting

This study will evaluate the efficacy, safety, and pharmacokinetics of prasinezumab compared with placebo in patients with early Parkinson's disease (PD).

Contact: Rylee Manka 217-545-1394
Trial
Psychiatry

RECOVER: A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No-Stimulation Control in Subjects with Treatment-Resistant Depression

Active recruiting

The RECOVER study is a nationwide clinical trial that has been approved by Medicare to provide additional evidence for the benefits of Vagus Nerve Stimulation (VNS) Therapy.  Vagus Nerve Stimulation Therapy is an FDA-approved device for treating patients with TRD (Treatment Resistant Depression). It is implanted in the left chest area during a short outpatient procedure. The device delivers mild, intermittently pulsed signals to the vagus nerve in the neck that activate various parts of the brain.

Contact: Oladele (Dickson) Owasoyo 217-545-7231
Profiles
Richard Selinfreund

Richard Selinfreund, PhD

Associate Professor & Head of Pathology Group
Medical Microbiology, Immunology and Cell Biology
General Results

Diagnostic Radiology Resident Benefits

Learn more about salary and other GME benefits here . Radprimer and STAT DX subscriptions $500 Book Fund $2000 Tuition for AIRP and $1,800 housing stipend $1250 for Physics Review Course Free catered lunch at noon conferences Doctors Lounge at Springfield Memorial Hospital and St. John's Hospital with free access to 24-hour food, coffee/beverages, and hot breakfast/lunch Free ACLS courses Free covered parking at both rotation sites 7 calendar days per year for attendance at recognized educational meetings. Reimbursement of travel, lodging, and tuition expenses for paper or poster presentations
Subscribe to